Information about Pharmanext
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0705.998.068

VAT liability
Yes
Established
28-09-2018
Last balance sheet year
2025
Company size
Medium-sized 3,6 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Pharmanext

2025 2024 2023 2022
Profit/Loss 169,596 21,61% 139,464 77,55% 78,551 7,33% 73,185
Equity 531,183 20,29% 441,587 32,96% 332,123 30,98% 253,572
Gross margin 485,409 7,18% 452,903 13,18% 400,166 7,74% 371,436
Employees 3.6 3.5 3.4 3.5

Publications from Pharmanext

Date Publication
12-04-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations, Appointments (FR)
04-08-2022 Resignations, Appointments (FR)
02-10-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Pharmanext?
The VAT number of Pharmanext is BE 0705.998.068.
Wat is the PEPPOL ID of Pharmanext?
The PEPPOL ID of Pharmanext is 0208:0705998068. Log in or start a free trial to see the full overview.
When was Pharmanext founded?
Pharmanext was founded on 28-09-2018.
What is the address of Pharmanext?
The current registered office of Pharmanext is located at Square du Solbosch 30, 1050 Ixelles.
When was the last time Pharmanext filed their annual financial statements?
The most recent financial statements of Pharmanext were filed on 01-07-2026.
How many employees does Pharmanext have?
There are 3,6 FTEs working at Pharmanext according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharmanext?
At the time of its most recent financial statements, Pharmanext did not publish any turnover figures. Pharmanext reported a gross margin of €485,408.88.